Last deal

$6.4M
Local Amount - EUR 6.M

Amount

Post-IPO Equity

Stage

12.11.2023

Date

6

all rounds

$66.9M

Total amount

General

About Company
Mauna Kea Technologies designs and sells optical biopsy devices and tools for medical diagnosis and treatment.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Mauna Kea

founded date

01.01.2000

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Mauna Kea Technologies is a global medical device company that generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company's technology is revolutionizing the way physicians diagnose and treat patients, providing real-time in vivo cellular visualization that enables them to monitor the progression of disease over time, assess point-in-time reactions, classify indeterminate areas of concern, and guide surgical interventions.
Contacts

Phone number

Social url